# Vakaramoko Diaby

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/vakaramoko-diaby/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,779 |
| Field | Health Systems, Economic Evaluations, Quality of Life |
| h-index | 19 |
| i10-index | 37 |
| Last Known Institution | Santa Fe College |
| OpenAlex ID | https://openalex.org/A5079353897 |
| ORCID iD | 0000-0002-6251-0773 |
| Works | 135 |

## Researcher papers

- [Application of multicriteria decision analysis in health care: a systematic review and bibliometric analysis](https://scholariq.org/papers/application-of-multicriteria-decision-analysis-in-health-care-a-systematic/)
- [Multi-criteria decision analysis (MCDA) in health care: A bibliometric analysis](https://scholariq.org/papers/multi-criteria-decision-analysis-mcda-in-health-care-a-bibliometric-analysis/)
- [Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward](https://scholariq.org/papers/multicriteria-decision-analysis-to-support-health-technology-assessment-agencies/)
- [A review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancer](https://scholariq.org/papers/a-review-of-systematic-reviews-of-the-cost-effectiveness-of-hormone-therapy/)
- [Survival Modeling for the Estimation of Transition Probabilities in Model-Based Economic Evaluations in the Absence of Individual Patient Data: A Tutorial](https://scholariq.org/papers/survival-modeling-for-the-estimation-of-transition-probabilities-in-model-based/)
- [How to use multi-criteria decision analysis methods for reimbursement decision-making in healthcare: a step-by-step guide](https://scholariq.org/papers/how-to-use-multi-criteria-decision-analysis-methods-for-reimbursement-decision/)
- [Sedative-Hypnotic Medicines and Falls in Community-Dwelling Older Adults: A Cost-Effectiveness (Decision-Tree) Analysis from a US Medicare Perspective](https://scholariq.org/papers/sedative-hypnotic-medicines-and-falls-in-community-dwelling-older-adults-a-cost/)
- [Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States](https://scholariq.org/papers/cost-effectiveness-analysis-of-1st-through-3rd-line-sequential-targeted-therapy/)
- [Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data](https://scholariq.org/papers/cost-effectiveness-of-cyp2c19-guided-antiplatelet-therapy-in-patients-with-acute/)
- [Multicriteria decision analysis in oncology](https://scholariq.org/papers/multicriteria-decision-analysis-in-oncology/)
- [Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer](https://scholariq.org/papers/comparative-cost-effectiveness-of-radiotherapy-among-older-women-with-hormone/)
- [Burden of corticosteroid therapy in patients with immunoglobulin A nephropathy (IgAN): a systematic literature review](https://scholariq.org/papers/burden-of-corticosteroid-therapy-in-patients-with-immunoglobulin-a-nephropathy/)

## Researcher topics

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

## Researcher university

- [Santa Fe College](https://scholariq.org/institutions/santa-fe-college/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.